How The US FDA Finds Pre-Approval Inspection Alternatives During COVID-19 Pandemic
Officials explain how remote record reviews, site transfers and other factors can green-light approvals of drugs and biologics.
Officials explain how remote record reviews, site transfers and other factors can green-light approvals of drugs and biologics.